James W. Freston, M.D., Ph.D., is the Boehringer Ingelheim Chair of Clinical Pharmacology and professor emeritus at the University of Connecticut School of Medicine at Farmington. Dr. Freston's research interests include the clinical pharmacology of digestive diseases, including acid-related disorders and drug-induced liver injury. He is a member of the NIDDK-funded National Drug-Induced Liver Injury Network (DILIN). Dr. Freston was appointed to the NIDDK Advisory Council last year for a one-year term and has been reappointed this year for a four-year term. He will continue to serve on the Digestive Diseases and Nutrition (DDN) Subcommittee.

James P. Schlicht, M.P.A., is executive vice president and chief government affairs and advocacy officer at the American Diabetes Association (ADA). Mr. Schlicht is a member of the senior management team at the ADA and reports directly to the ADA chief executive officer. He is directly responsible for management of all advocacy and government affairs functions and is responsible for formulation, adoption, strategic development and implementation of all public policy positions of the ADA. Prior to joining the ADA, Mr. Schlicht worked for several pharmaceutical companies in the area of government affairs. He also served as a management analyst in the U.S. General Accounting Office and as a budget specialist in the U.S. Office of Management and Budget before serving as a staff aide to the U.S. House Ways and Means Committee. Mr. Schlicht joins the Diabetes, Endocrinology, and Metabolic Diseases (DEM) Subcommittee.


NIDDK conducts and supports research in diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe, and disabling conditions affecting Americans. For more information about NIDDK and its programs, see www.niddk.nih.gov.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Back to HCB News

More Voices